HomeTagsAscentage Pharma

Ascentage Pharma

Biotechnology

Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918

PR Newswire - November 10, 2022

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that its novel...

Biotechnology

AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387

PR Newswire - November 7, 2022

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it has...

Biotechnology

EHA 2022 | Ascentage Pharma Releases Encouraging Results of Bcl-2 Inhibitor Lisaftoclax (APG-2575)

PR Newswire - June 14, 2022

Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it...

Resilinc Announces Chris Lanier as New Chief Technology Officer

SkySafe and Fortem Partner to Enhance Drone Detection and Mitigation

Cequence Security and AWS Team Up for Advanced API Protection and…

PCS Software Appoints Danielle Villegas as Chief Product Officer

Ascentage Pharma

Hot Topics

Resilinc Announces Chris Lanier as New Chief Technology Officer

SkySafe and Fortem Partner to Enhance Drone Detection and Mitigation

Cequence Security and AWS Team Up for Advanced API Protection and Bot Management